Year |
Citation |
Score |
2020 |
Pastar I, O'Neill K, Padula L, Head CR, Burgess JL, Chen V, Garcia D, Stojadinovic O, Hower S, Plano GV, Thaller SR, Tomic-Canic M, Strbo N. Boosts Innate Immune Response by Activation of Gamma Delta T Cells and Induction of Perforin-2 in Human Skin. Frontiers in Immunology. 11: 550946. PMID 33042139 DOI: 10.3389/Fimmu.2020.550946 |
0.355 |
|
2020 |
Singh C, Lee H, Tian Y, Schesser Bartra S, Hower S, Fujimoto LM, Yao Y, Ivanov SA, Shaikhutdinova RZ, Anisimov AP, Plano GV, Im W, Marassi FM. Mutually constructive roles of Ail and LPS in Yersinia pestis serum survival. Molecular Microbiology. PMID 32462782 DOI: 10.1111/Mmi.14530 |
0.343 |
|
2018 |
Bai F, McCormack RM, Hower S, Plano GV, Lichtenheld MG, Munson GP. Perforin-2 Breaches the Envelope of Phagocytosed Bacteria Allowing Antimicrobial Effectors Access to Intracellular Targets. Journal of Immunology (Baltimore, Md. : 1950). PMID 30249808 DOI: 10.4049/Jimmunol.1800365 |
0.353 |
|
2012 |
Bullock HD, Hower S, Fields KA. Domain analyses reveal that Chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins. The Journal of Biological Chemistry. 287: 28078-86. PMID 22711538 DOI: 10.1074/Jbc.M112.386904 |
0.556 |
|
2009 |
Hower S, Wolf K, Fields KA. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Molecular Microbiology. 72: 1423-37. PMID 19460098 DOI: 10.1111/J.1365-2958.2009.06732.X |
0.584 |
|
2006 |
Wolf K, Betts HJ, Chellas-Géry B, Hower S, Linton CN, Fields KA. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Molecular Microbiology. 61: 1543-55. PMID 16968227 DOI: 10.1111/J.1365-2958.2006.05347.X |
0.529 |
|
Show low-probability matches. |